Last reviewed · How we verify
NCT07356297
Comparing Remotely-delivered Interventions to Promote Cessation Among Adults Who Smoke Menthol Cigarettes
NA trial testing Quitline (QL) in Cigarette Smoking in 1,200 participants. Not yet recruiting.
1 April 2030
Quick facts
| Lead sponsor | University of Michigan |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 1,200 |
| Start date | 1 September 2026 |
| Primary completion | 1 April 2030 |
| Estimated completion | 1 April 2030 |
Drugs / interventions tested
- Quitline (QL)
- Mobile incentive-based intervention
Conditions studied
- Cigarette Smoking — all drugs for Cigarette Smoking →
Sponsor
University of Michigan
Who can join
18 and older, any sex, with Cigarette Smoking. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Smoking Cessation
Time frame: 3-, 6-, 9- and 12- months post baseline
Participants will self-report (yes/no) past 30-day combustible tobacco use.
Sponsor's own description
The purpose of this study is to evaluate whether a digital, incentive-based program, used in conjunction with traditional quitline (QL) services, can be beneficial to quitline callers who smoke menthol cigarettes. The services evaluated focus on coaching, support, and/or incentives for individuals who wish to quit smoking.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07356297
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cigarette Smoking
Currently open trials in the same condition.
- NCT07161050 — Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing · NA · recruiting
- NCT07014124 — Smoking Cessation for Fathers of Sick Children · NA · recruiting
- NCT06678789 — Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches · NA · recruiting
- NCT06609083 — Effect of Cannabis on Cigarette Use Behavior · Phase 1 · recruiting
- NCT05587361 — Beta-Adrenergic Modulation of Drug Cue Reactivity · Phase 4 · recruiting
Other University of Michigan trials
Trials by the same sponsor.
- NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
- NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
- NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
- NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
- NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07356297 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Michigan
- Last refreshed: 20 May 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07356297.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing